HomeITCI • NASDAQ
add
Intra-Cellular Therapies Inc
Previous close
$128.20
Day range
$131.20 - $131.35
Year range
$63.30 - $131.35
Market cap
13.92B USD
Avg Volume
2.77M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 199.22M | 50.81% |
Operating expense | 137.73M | 31.52% |
Net income | -16.88M | 40.92% |
Net profit margin | -8.48 | 60.80% |
Earnings per share | -0.16 | 46.67% |
EBITDA | -29.09M | 14.35% |
Effective tax rate | 1.84% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.00B | 101.04% |
Total assets | 1.37B | 87.69% |
Total liabilities | 218.45M | 59.60% |
Total equity | 1.15B | — |
Shares outstanding | 106.33M | — |
Price to book | 11.86 | — |
Return on assets | -5.42% | — |
Return on capital | -6.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -16.88M | 40.92% |
Cash from operations | -13.08M | -534.55% |
Cash from investing | -149.89M | -416.08% |
Cash from financing | 5.61M | 86.62% |
Net change in cash | -157.36M | -425.37% |
Free cash flow | -2.93M | -105.46% |
About
Founded
2002
Headquarters
Website
Employees
860
